Print
Article
Volume 1.1
Pills in a World of Activism and ESG
Caley Petrucci
Climenko Fellow & Lecturer on Law, Harvard Law School

Comments welcome at cpetrucci@law.harvard.edu

Guhan Subramanian
Joseph Flom Professor of Law & Business, Harvard Law School; Douglas Weaver Professor of Business Law, Harvard Business School; Faculty Chair, Harvard Law School Program on Negotiation; Faculty Chair, Harvard Business School Mergers & Acquisitions Executive Education Program; Chairman of the Board of Directors, LKQ Corp. (NASDAQ: LKQ)

Professor Subramanian served as an expert witness for The Williams Companies and Versum Materials, Inc. in the poison pill litigation that is discussed in the text. We thank participants at the University of Chicago Business Law Review Symposium and the Harvard JD/MBA Seminar for their thoughtful comments on earlier drafts. We also thank Marc Schwab for his excellent research assistance.

Print
Comment
Volume 1.1
Who Can Tax Telecommuters?: A Case for an Economic Presence Regime
Garry Canepa
J.D. 2022, The University of Chicago Law School

Many thanks to Professor Julie Roin for her useful feedback and rigorous criticisms, making any faults in reasoning my own. Thanks to The University of Chicago Business Law Review editors for their extensive comments and edits.

I. Introduction

Print
Comment
Volume 1.1
Mandatory Financial Disclosures as Total Regulatory Takings
Jay Khurana
MAcc 2018, Case Western Reserve University; B.S. 2017, Case Western Reserve University; J.D. Candidate 2023, The University of Chicago Law School

Many thanks to the staff and editors of the University of Chicago Business Law Review and to Professor Douglas Baird for their helpful feedback.